1,158
-1.53%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About KNC Laboratories Co
Its shares trade on Tokyo Stock Exchange under the ticker 6568.T. It has been listed since 15 March 2018. In the fiscal year to 31 March 2026, it reported revenue of ¥9.09bn and net income of ¥766.2m. At that date it held total assets of ¥21.64bn and shareholders' equity of ¥14.08bn.
KNC Laboratories Co., Ltd. engages in research, development, and production solutions for organic chemicals. The company is headquartered in Kobe, Hyogo-Ken. The company went IPO on 2018-03-15. The firm supplies necessary samples and products for research, development and production activities for product development, manufacture and sale, and also examines the manufacturing method. Organic chemical products are chemical products and intermediates used in the field of medicine and information electronics. Products include display materials, chemicals for semiconductor manufacturing, herbicides, fungicides, drug substances and intermediates, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 15 Mar 2018
- Employees
- 291
- Website
- kncweb.co.jp ↗
Leadership
Pay as last reported
- Mr. Takuya MookaPresident, Chief Director of Administration, Representative Director, since 2016
- Mr. Masahiro NeyaManaging Director, Director of Reliability Assurance Promotion
- Mr. Koji MatsuoExecutive Officer, Director of Sales Management, since 2022
- Mr. Atsushi KaetsuExecutive Officer, Director of Pharmaceutical Business
- Mr. Junichi MiyaharaExecutive Officer, Director of Biotechnology Business, Director of Life Science
- Mr. Kimihiro KamasakaDirector of Functional Materials Business, Director
- Mr. Hidemi YoshidaDirector of Functional Materials Business, Director, since 2018
- Mr. Ryuichi InoueDirector, since 2023
- Mr. Osamu MaruyamaIndependent Director
- Mr. Mitsukuni MoriIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- KNC Laboratories employs 291 full-time staff in Kobe for chemical research.
- The firm supplies organic chemical intermediates for medicine and electronics.
- Display materials and semiconductor chemicals support diverse industrial production needs.
Weaknesses
- The company went public on 15 March 2018 with limited history.
- Operations are concentrated in Kobe, Hyogo-Ken, Japan, limiting geographic reach.
- Only 291 employees may restrict large-scale global production capabilities.
Opportunities
- Growing demand for semiconductor manufacturing chemicals offers expansion potential.
- Development of new drug substances can increase market share.
- Supplying herbicides and fungicides meets agricultural industry requirements.
Threats
- Competition in the chemical sector may reduce profit margins.
- Regulatory changes in Japan could impact organic chemical production.
- Fluctuations in raw material costs affect manufacturing expenses.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.